Status:
NOT_YET_RECRUITING
PET Imaging of 68Ga-NOTA-H006 in Malignancy
Lead Sponsor:
YiHui Guan
Conditions:
Tumor, Solid
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
5T4, also known as trophoblast glycoprotein, is an oncofoetal antigen expressing in fetal development and cancer but rarely in adult. The high expression of 5T4 in malignancy was found be associated w...
Eligibility Criteria
Inclusion
- Pancreatic cancer clinical trial study subjects must meet all of the following criteria:
- Age between 18 and 65 years old.
- Pancreatic occupancy is found on imaging and combined with clinical judgment as a patient with pancreatic cancer.
- Written informed consent signed by the subject or his/her legal guardian or caregiver.
- Willingness and ability to cooperate with all programs of the study.
- Lung cancer clinical trial study subjects must meet all of the following criteria:
- Be between the ages of 18 and 65 years old.
- Patients with CT findings of suspicious space on the lungs with a diameter of more than 1cm who have not undergone surgery.
- Written informed consent must be signed by the subject or his/her legal guardian or caregiver.
- Willingness and ability to cooperate with all programs of the study.
- Bowel cancer clinical trial study subjects must meet all of the following criteria:
- Be between the ages of 18 and 65.
- Have a clear histologic or pathologic diagnosis of colorectal cancer.
- Written informed consent signed by the subject or legal guardian or caregiver.
- Willingness and ability to cooperate with all programs of this study.
Exclusion
- Severe hepatic or renal insufficiency;
- Targeted therapy prior to radiotherapy or PET/CT scan. 5T4 expression in existing lesions assessed by immunohistochemistry using antibody clones.
- History of serious surgery in the last month.
- Those who have participated in other clinical trials during the same period.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06162988
Start Date
December 1 2023
End Date
December 1 2028
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huashan Hospital
Shanghai, China, 200040